Baton Rouge, LA – According to filings with the U.S. Securities and Exchange Commission, Oleander Medical Technologies is raising $4,000,000.00 in new funding. Sources indicate as part of senior management President, Paige Miller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Oleander Medical Technologies

Oleander Medical Technologies is developing a revolutionary new treatment to destroy many of the most invasive and deadly cancers using a process called Targeted Osmotic Lysis (TOL). Unlike radiation or chemotherapy, TOL has the potential to destroy cancer without ravaging the rest of the body, to eliminate the disease in a matter of minutes, without pain and with minimal discomfort, and at a much lower cost than current treatments.

To learn more about Oleander Medical Technologies, visit http://www.oleandermedicaltechnologies.com/

Contact:
Paige Miller, President
225-413-7658
pmiller@oleandermedicaltechnologies.com
https://www.linkedin.com/in/paige-miller-b25aa919/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved